Salem Capital Management Inc has filed its 13F form on November 29, 2022 for Q3 2022 where it was disclosed a total value porftolio of $126 Million distributed in 55 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $8.86M, Merck & Co., Inc. with a value of $7.04M, Pfizer Inc with a value of $6.05M, Bank Of America Corp with a value of $5.97M, and Honeywell International Inc with a value of $5.59M.

Examining the 13F form we can see an decrease of $10.8M in the current position value, from $137M to 126M.

Below you can find more details about Salem Capital Management Inc portfolio as well as his latest detailed transactions.

Portfolio value $126 Million
Technology: $23.3 Million
Healthcare: $21.2 Million
Energy: $18.4 Million
Consumer Cyclical: $16.9 Million
Industrials: $14 Million
Financial Services: $13.2 Million
Real Estate: $5.67 Million
Consumer Defensive: $4.7 Million
Other: $6.6 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 55
  • Current Value $126 Million
  • Prior Value $137 Million
  • Filing
  • Period Q3 2022
  • Filing Date November 29, 2022
  • Form Type 13F-HR
  • Activity in Q3 2022
  • New Purchases 0 stocks
  • Additional Purchases 12 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 9 stocks
Track This Portfolio

Track Salem Capital Management Inc Portfolio

Follow Salem Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Capital Management Inc with notifications on news.